Actively Recruiting
Pulse Arrival Time as an Alternative Biomarker to Detect Lower-Extremity Peripheral Artery Disease
Led by University of Nebraska · Updated on 2026-05-19
60
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating segmental pulse arrival time (PAT) as a possible new biomarker to detect lower-extremity peripheral artery disease (PAD) and to study how local skin heating, foot elevation, and age affect PAT. The study includes adults aged 19 or older, with or without PAD. It aims to determine if PAT can predict PAD compared to the standard ankle-brachial index (ABI) and how these factors influence the measurements. Participants will attend a single laboratory visit where descriptive measurements like height, weight, body fat, age, and sex are recorded. They will rest lying down for 20 minutes before having either ABI or PAT measured first, then the other test after 10 minutes of rest. PAT is measured using a special device with sensors on the fingers and toes that monitor heart and blood flow signals while the skin temperature is adjusted and the feet are elevated. ABI uses blood pressure cuffs and Doppler ultrasound to measure blood pressure in the arms and legs. After these tests, participants complete a 6-minute walking test to assess exercise capacity. During the visit, blood pressure is taken at various stages, and thermal images of the fingers and toes are captured to record skin temperature changes. The study lasts about 2.5 hours with no follow-up visits. Researchers compare PAT results with ABI and walking test outcomes to evaluate PAT's accuracy in detecting PAD and related walking difficulties. Safety is monitored throughout the visit, and participants' usual care continues unaffected.
CONDITIONS
Brief Title
Detecting Peripheral Artery Disease With the Pulse
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be able to provide written informed consent
- Be 19 years of age or older
- Have or not have a diagnosis of peripheral artery disease
You will not qualify if you...
- Have a current or previous aortic aneurysm with or without previous intervention
- Have had previous revascularization surgeries of the legs or aorta
- Have walking impairments not caused by lower-limb ischemia
- Have gangrene or ulcers of the toes or feet
- Be currently pregnant or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 2.5 hours
Participants attend a single laboratory visit where segmental pulse arrival times are assessed with an investigational device, ankle-brachial index measurements are performed, and a 6-minute walking test is conducted to evaluate lower-extremity peripheral artery disease.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
University of Nebraska at Omaha Health Science Collaborative
Omaha, Nebraska, United States, 68182
Actively Recruiting
Research Team
C
Cody P Anderson
G
Gwenael Layec, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here